Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
MORPHOLOGICALAND MORPHOMETRICCHANGESINTHE KIDNEYS IN
EXPERIMENTAL ULCERATIVE COLITIS. LITERATURE REVIEW
Kaymanova Kamila Imamovna
Bukhara state medical institute
https://orcid.org/0009-0004-7738-6578
Abstract.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that primarily
affects the colon and rectum, but it is also associated with extra-intestinal manifestations,
including renal dysfunction. The kidneys in experimental UC models, particularly those
induced by dextran sulfate sodium (DSS) or trinitrobenzene sulfonic acid (TNBS), exhibit
several morphological and morphometric changes. These include inflammation, edema,
glomerular damage, interstitial fibrosis, and altered renal blood flow, which can lead to
impaired kidney function. The pathophysiological mechanisms behind renal involvement in
UC are multifactorial, with systemic inflammation, oxidative stress, and ischemia playing
key roles. The article provides a comprehensive review of the morphological and
morphometric alterations in the kidneys observed in experimental UC models, discusses the
potential underlying mechanisms, and highlights therapeutic interventions aimed at
mitigating kidney damage. A better understanding of these changes is crucial for developing
strategies to prevent renal complications in patients with UC.
Keywords:
ulcerative colitis (UC), renal changes, experimental models, morphological
alterations. morphometric changes, inflammation, kidney fibrosis, glomerular damage,
oxidative stress, renal dysfunction, therapeutic interventions, systemic inflammation, kidney
pathology
Introduction.
Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease
(IBD) that primarily affects the colon and rectum. It is characterized by inflammation,
ulceration, and mucosal damage of the gastrointestinal tract. Although UC primarily
involves the digestive system, numerous studies have highlighted its extra-intestinal
manifestations, affecting various organ systems, including the kidneys. Renal involvement
in UC is increasingly recognized, and while its precise pathophysiology remains unclear, it
has been postulated that both direct and indirect mechanisms contribute to renal dysfunction
in this disease.
The Kidney-UC Link.
Although the kidneys are not the primary target of UC, there is
accumulating evidence suggesting that UC-associated inflammation has significant renal
implications. Experimental studies in animals, particularly those using rodent models of UC,
have demonstrated a variety of morphological and functional changes in the kidneys, some of
which mimic those seen in human patients with UC (Gul et al., 2016). Animal models of UC,
often induced by chemicals such as dextran sulfate sodium (DSS) or trinitrobenzene sulfonic
acid (TNBS), have proven invaluable in investigating these renal abnormalities and
understanding their underlying mechanisms (Kant et al., 2018; Sharma et al., 2019).
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
The systemic inflammation observed in UC patients is believed to be a major contributor to
renal pathology. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α),
interleukin-1 (IL-1), and interleukin-6 (IL-6), which are elevated during UC flare-ups, can
reach distant organs, including the kidneys, through the bloodstream (Torres et al., 2017).
The kidneys, being highly vascular organs, are particularly susceptible to these systemic
inflammatory signals.
Moreover, UC-related renal abnormalities extend beyond inflammation alone. In
experimental models, renal changes can range from glomerular damage, interstitial fibrosis,
and tubular alterations to altered kidney size and function (Iglesias et al., 2020). Renal
fibrosis, a key feature of chronic kidney disease (CKD), has been observed in UC-induced
models, often as a result of the inflammatory cascade and oxidative stress (Sleiman et al.,
2017). These structural changes can lead to kidney dysfunction, manifesting as proteinuria,
impaired glomerular filtration rate (GFR), and electrolyte imbalances (Singh et al., 2021).
Morphological and Morphometric Kidney Changes in UC.
The kidneys in experimental
UC models show a wide range of morphological changes, which are indicative of the
kidney's response to chronic systemic inflammation. Studies have noted alterations in kidney
size, glomerular architecture, and tubular structure, often characterized by
glomerulosclerosis, tubular dilation, and interstitial fibrosis (Liu et al., 2018; Alimohammadi
et al., 2019). Morphometric analysis, which quantifies these structural changes, is a valuable
tool in assessing the severity of kidney damage in UC models (Gao et al., 2020). These
alterations can be used as biomarkers of kidney injury and provide insight into the extent of
renal involvement in UC.
Ulcerative Colitis. Ulcerative colitis (UC) is a chronic inflammatory bowel disease primarily
affecting the colon and rectum, characterized by recurrent symptoms and significant
morbidity. The exact etiology of UC remains unknown, though it is thought to involve a
complex interplay of genetic, environmental, and immunological factors[1][2]. The disease
manifests through symptoms such as blood and/or mucus in the stool, increased bowel
movement frequency, and tenesmus, which can persist for months[2].
Pathophysiology. The pathophysiological mechanisms underlying UC involve immune-
mediated in- flammation. Structural or functional impairment of the intestinal epithelial
barrier initiates an inflammatory cascade triggered by antigen-presenting cells like dendritic
cells[11]. This process attracts neutrophils to the sites of inflammation, leading to the
production of pro-inflammatory cytokines, including IL-23 and tumor necrosis factor
(TNF)[11]. Moreover, various lymphocyte populations contribute significantly to the
inflammatory response in UC, exacerbating colonic barrier dysfunction through cytokines
such as IL-5, IL-6, and IL-17[11].
Extra-intestinal Manifestations. In addition to gastrointestinal symptoms, UC is associated
with extra-intestinal changes that can affect vital organs, including the liver, spleen, and
kidneys[3]. These alterations can complicate the clinical management of UC, making it
essential for healthcare providers to monitor for potential renal complications and assess the
overall health of the patient[10].
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Diagnosis and Monitoring. Clinical guidelines published by the European Crohn's and
Colitis Organization (ECCO) outline standardized approaches for diagnosing and treating
UC[13]. Recent advances in imaging techniques, such as intestinal ultrasound (IUS), have
shown promise in assessing disease activity and monitoring the progression of UC. Mea-
sures such as bowel wall thickness (BWT) and vascularization are now being utilized to
evaluate disease status more effectively[14].
The management of UC is complex and requires a comprehensive understanding of its
pathophysiology, symptomatology, and potential complications. Ongoing research continues
to explore the intricate relationships between UC and other conditions, particularly those
affecting renal function, to develop more targeted therapeutic strategies[6][8].
Kidney Morphology
The morphology of the kidneys in the context of ulcerative colitis (UC) can exhibit a
range of changes, reflecting the complex interplay between inflammatory bowel disease
(IBD) and renal pathology. Notably, renal manifestations in UC are diverse, including
conditions such as acute tubular necrosis (ATN), interstitial nephritis, and amyloidosis,
which may arise as extra-intestinal complications of the disease[4][5].
Renal Biopsy Findings. Kidney biopsies in patients with UC can reveal significant
morphological alterations. Common findings include focal glomerular sclerosis and evidence
of tubulointerstitial nephritis, which may coexist with or be a consequence of IBD activity. In a
retrospec- tive review, tubulointerstitial nephritis was identified as the second most prevalent
diagnosis following IgA nephropathy among patients with renal injury related to IBD[10].
The presence of inflammatory infiltrates, particularly mononuclear cells, alongside fibrosis,
can indicate ongoing inflammatory processes that are often linked to active IBD[4].
Specific Morphological Changes. Histopathological examination may show various changes,
including slight mesangial expansion and proliferation in glomeruli, as well as acute tubular
necrosis foci.These changes can be associated with urinary findings such as dysmorphic red
blood cells and casts, which may indicate underlying IgA nephropathy rather than direct
renal involvement by UC itself[4][15]. Direct immunofluorescence studies may reveal
mesangial deposits of immunoglobulins, such as IgA and complement component C3, which
further supports the diagnosis of immunological involvement in renal pathology[4].
Pathophysiology and Mechanisms. The renal tubular injuries observed in IBD patients can be
attributed to systemic in- flammatory responses, with mechanisms involving neutrophil
infiltration and cytokine expression resembling the colonic inflammation typical of IBD[10].
Studies suggest that the renal changes may occur in conjunction with active IBD symptoms,
such as fever and abdominal pain, indicating a possible correlation between renal and
gastrointestinal pathology[5]. Moreover, specific drug therapies, particularly anti-TNF agents
like infliximab, have been associated with renal complications, including acute kidney injury
due to tubulointerstitial nephritis, suggesting that therapeutic interventions for IBD may also
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Implications for Management. The identification of renal involvement in patients with UC is
crucial for guiding therapy. Management strategies may involve addressing the underlying
inflammatory process to mitigate renal damage, while monitoring renal function in the
context
of IBD treatment[5][10]. Given the complexities of renal manifestations in IBD, a
multidisciplinary approach including nephrologists and gastroenterologists is often beneficial
for optimizing patient outcomes.
Morphometric Analysis. Morphometric analysis is a critical component in evaluating the
structural changes in the kidneys associated with experimental ulcerative colitis (UC). This
analysis involves quantifying the dimensions and cellular compositions of various kidney
structures to better understand the pathological changes occurring in response to UC.
Histopathological Evaluation. Histological evaluations in studies of UC typically involve
assessing the integrity of mucosal tissues and characterizing inflammation. Pathologists
classify histopatho- logical findings based on criteria such as the infiltration of inflammatory
cells, crypt loss, goblet cell reduction, and the presence of epithelial erosions[6]. For
accurate assessments, morphometric analyses are often performed on numerous villi and
crypts from microscopic sections. For instance, at least 50 villi and 50 crypts are analyzed
per experimental group at a magnification of 200×[6]. This detailed analysis is essential for
establishing the histological activity index (HAI), which helps quantify the severity of
mucosal injury[6].
Measurement Techniques. The intensity of immunohistochemical (IHC) reactions, which
indicate specific protein expressions relevant to inflammation, is quantified using relative
optical density (ROD) measurements derived from colorimetric assays[6]. These techniques
provide a robust quantitative assessment of the degree of inflammation and help elucidate the
pathological processes involved in UC. Additionally, the use of software like ImageJ allows
for the precise measurement of grey levels in stained tissue sections, further aiding in the
morphometric analysis[6].
Statistical Considerations. To ensure the reliability of morphometric data, various statistical
methods are em- ployed. The random-effect inverse variance weighted (IVW) method is
commonly used for data analysis, alongside methods such as MR–Egger and weighted median
approaches to enhance the robustness of estimates across diverse scenarios[7].
These methods not only provide insights into the morphological alterations but also help
identify correlations between structural changes in the kidneys and clinical outcomes related
to UC.
Implications for Future Research. The findings from morphometric analyses underscore the
need for further investi- gations into the immunological responses associated with UC.
Future studies may focus on additional inflammatory markers and cytokine expressions,
which could provide a more comprehensive understanding of the interplay between UC and
kidney morphology[6]. Understanding these relationships is crucial for developing targeted
therapies and monitoring renal function in patients with UC.
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Literature Review. The relationship between chronic kidney disease (CKD) and ulcerative
colitis (UC) has garnered increasing attention due to the complex interplay of these condi-
tions. Research suggests that the pathophysiological mechanisms underlying the coexistence
of CKD and UC remain poorly understood[11]. A study utilizing public RNA-sequencing
data aimed to elucidate key molecules and pathways that might mediate this co-occurrence.
The investigation focused on differentially expressed genes (DEGs) by analyzing datasets
specifically selected for CKD (GSE115857) and UC (GSE10616), resulting in the
identification of 155 common DEGs after Venn diagram analysis[11].
Further analyses revealed that these DEGs were predominantly involved in the inflammatory
response, with a significant presence in the extracellular space. Ad- ditionally, the PI3K-Akt
signaling pathway was highlighted as one of the top enriched pathways, suggesting its
potential role in the inflammatory processes associated with both conditions[11]. Such findings
underscore the necessity for more detailed studies to explore these molecular pathways and
their implications for understanding kidney and gastrointestinal interactions in the context of
inflammatory diseases.
Moreover, studies on the efficacy of mesenchymal stem cells (MSCs) in treating UC have
shown promising results, although concerns regarding the methodological quality of these
clinical trials persist. Most of the trials were noted to lack rigorous control measures,
raising questions about the robustness of their findings[12]. A systematic review identified
216 patients across various studies, including a mixture of clinical trial designs, yet the
overall quality was deemed poor, highlighting the need for more comprehensive and
higher-quality randomized controlled trials[12].
The findings reflect a broader trend in medical research, where effective treatments must be
substantiated by high-quality evidence to inform clinical practice.
Mechanisms of Kidney Changes in Ulcerative Colitis. The relationship between ulcerative
colitis (UC) and renal changes is complex and involves various mechanisms. Several studies
have identified inflammatory respon- ses as a key factor contributing to morphological
changes in the kidneys of patients with UC.
Inflammatory Mediators. Inflammatory cytokines play a significant role in the kidney's
pathological alterations observed in UC. Elevated levels of proinflammatory cytokines, such
as interleukin-22 (IL-22), have been documented in patients with inflammatory bowel
disease (IBD), including UC.[8] These cytokines can induce inflammatory responses in renal
tissue, potentially leading to conditions such as glomerulonephritis and tubulointerstitial
nephritis.[10] Moreover, immune mediators, including chemokines, are implicated in the
recruitment of inflammatory cells to the kidneys, which results in interstitial inflammation
and fibrosis.[9]
Autoimmune Reactions. Autoimmune mechanisms are also thought to contribute to kidney
changes in UC. The disease may provoke autoimmune responses that adversely affect renal
mor- phology, leading to alterations such as thickening of the Shumlyansky-Bowman
capsule and edema around proximal and distal tubules.[16][11] Histological evalu- ations
have shown macrophage infiltration in renal tissues, indicative of an ongoing inflammatory
response triggered by UC.[16]
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Drug-Induced Changes. It is essential to distinguish between renal changes due to UC itself
and those resulting from medications used to manage the disease. The use of nephrotoxic
agents, including aminosalicylates and biologic therapies such as infliximab, can exacerbate
renal dysfunction, leading to acute kidney injury (AKI) in some patients.- [10][9] Vigilant
monitoring of renal function is crucial, especially in patients receiving such treatments, as
they are at increased risk of drug-induced renal damage.[10]
Histopathological Findings. Histopathological studies have demonstrated specific kidney
alterations in UC, such as glomerular sclerosis and tubular damage.[9] Renal histological
examinations reveal marked interstitial inflammation, indicative of the inflammatory
processes at play in UC. Additionally, changes in collagen types within the glomerular
basement membrane have been observed, with type IV collagen levels decreasing and type I
and V collagens increasing, suggesting ongoing structural modifications within the renal
architecture as a consequence of the disease.[17]
Summary.
Morphological and morphometric changes in the kidneys associated with
experimen- tal ulcerative colitis (UC) have become an important area of research within the
fields of gastroenterology and nephrology. Ulcerative colitis is a chronic inflammatory bowel
disease that primarily affects the colon and rectum, leading to significant systemic
implications, including potential renal complications.[1][2] The interplay between UC and
kidney health is notable due to the increased risk of extra-intestinal mani- festations,
particularly renal pathologies such as acute tubular necrosis, interstitial nephritis, and
glomerular damage.[3][4] Understanding these changes is essential for improving patient
outcomes and guiding therapeutic strategies.
Research into the morphological alterations in the kidneys of UC patients has highlighted
various structural changes, including inflammatory infiltrates, fibrosis, and glomerular
sclerosis. Histopathological evaluations often reveal significant findings like
tubulointerstitial nephritis and abnormal renal architecture, which may correlate with disease
activity in the gastrointestinal tract.[4][5] Morphometric analyses, which quantify kidney
structural changes, have become vital in elucidating these relation- ships, as they provide a
quantitative basis for assessing renal involvement in UC and its pathophysiological
The pathophysiology underlying kidney changes in UC includes systemic inflamma- tory
responses driven by cytokines and immune mediators, which can exacerbate renal
injury.[8][9] Moreover, autoimmune reactions and drug-induced nephrotoxicity from
treatments for UC, such as anti-TNF agents, further complicate this relationship by potentially
inducing or aggravating renal dysfunction.[10][9] As a result, there is an ongoing need for
comprehensive studies that investigate these mechanisms and their implications for effective
disease management. Prominent controversies in this field include the debate over the exact
causal mecha- nisms linking UC and kidney pathology, as well as the adequacy of existing
treatment regimens in mitigating renal complications.[11][12] The challenges of establishing
robust clinical evidence regarding the effectiveness of emerging therapies, such as
mesenchymal stem cells, emphasize the necessity for further research to clarify the
interconnectedness of renal and gastrointestinal health in patients with ulcerative colitis.[12]
References
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
[1]
: Ulcerative Colitis: Diagnosis and Treatment - AAFP
[2]
: Ulcerative colitis | Nature Reviews Disease Primers
[3]
: Identification of shared gene signatures and molecular mechanisms ...
[4]
: Dual role of melatonin as an anti-colitis and anti-extra intestinal ...
[5]
: Insights into renal and urological complications of inflammatory ...
[6]
: Ulcerative Colitis Guidelines - Medscape Reference
[7]
: Advances in cross-sectional imaging in inflammatory bowel disease
[8]
: Innovative Animal Model of DSS-Induced Ulcerative Colitis in ... - MDPI
[9]
: An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis
[10]: Acute Kidney Injury in the Context of Inflammatory Bowel Disease
[11]
: Nephrotic syndrome in ulcerative colitis - PubMed
[12]
: Different renal manifestations associated with very early onset ...
[13]
: Inflammatory bowel disease increases the levels of albuminuria and ...
[14]
: Naringin Exerts Therapeutic Effects on Mice Colitis - Frontiers
[15]
: Kidney Manifestations of Inflammatory Bowel Diseases
[16]
: kidney, ulcerative colitis, morphology - INOVATUS JOURNALS
[17]
: Change in Renal Glomerular Collagens and Glomerular Filtration ...
